Risk assessment in chronic myelomonocytic leukemia (CMML)

Leukemia and Lymphoma

Volumn 45, Issue 7, 2004, Pages 1311-1318

  Germing, U ^a   Kundgen A ^a   Gattermann, N ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Classification; CMML; Myelodysplastic syndromes; Prognosis; Scoring systems

Indexed keywords

HEMOGLOBIN; LACTATE DEHYDROGENASE;

ACUTE GRANULOCYTIC LEUKEMIA; BLAST CELL; CANCER DIAGNOSIS; CANCER GROWTH; CANCER REGISTRY; CANCER RISK; CANCER SURVIVAL; CELL COUNT; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL STUDY; DISEASE COURSE; HEMOGLOBIN DETERMINATION; HIGH RISK POPULATION; HUMAN; INTERMETHOD COMPARISON; KARYOTYPING; LACTATE DEHYDROGENASE BLOOD LEVEL; LYMPHOCYTE COUNT; MEDICAL DECISION MAKING; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RATING SCALE; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SURVIVAL TIME;

ACUTE DISEASE; AGED; BONE MARROW; DISEASE PROGRESSION; FEMALE; GERMANY; HEMOGLOBINS; HUMANS; L-LACTATE DEHYDROGENASE; LEUKEMIA, MYELOID; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; LIFE TABLES; MALE; MIDDLE AGED; NEOPLASM PROTEINS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 2542537480     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819042000207271     Document Type: Review

References (37)

1. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R. and Sultan, C. (1982) "Proposals for the classification of the myelodysplastic syndromes", British Journal of Haematology, 51, 189-199.
2. Aul, C., Gattermann, N. and Schneider, W. (1995) "Epidemiological and etiological aspects of myelodysplastic syndromes", Leukemia and Lymphoma, 16, 247-262.
3. Germing, U., Gattermann, N., Minning, H., Heyll, A. and Aul, C. (1998) "Problems in the classification of CMML. Dysplastic vs. proliferative type", Leukemia Research, 22, 871-878.
4. Michaux, J.L. and Martiat, P. (1993) "Chronic myelomonocytic leukaemia (CMML). A myelodysplastic or myeloproliferative syndrome?" , Leukemia and Lymphoma, 9, 35-41.
5. Strupp, C., Germing, U., Trommer, I., Gattermann, N. and Aul, C. (2000) "Pericardial effusion in chronic myelomonocytic leukemia", Leukemia Research, 24, 1059-1062.
6. Duguid, J.K., Mackie, M.J. and McVerry, B.A. (1983) "Skin infiltration associated with chronic myelomonocytic leukaemia", British Journal of Haematology, 53, 257-264.
7. Voglova, J., Chrobak, L., Neuwirtova, R., Malaskova, V. and Straka, L. (2001) "Myelodysplastic and myeloprolifierative type of chronic myelomonocytic leukemia", Leukemia Research, 25, 493-499.
8. Aul, C., Gattermann, N., Germing, U., Südhoff, T., Hollmig, K.A. and Heyll, A. (1997) "Fatal hyperleukocytic syndrome in a patient with chronic myelomonocytic leukemia", Leukemia Research, 21, 249-253.
9. Cervera, J., Sanz, G.F., Vallespie, T., del Canizo, M.C., Irriguible, D., Lopez, F., et al. (1997) "Does WBC really define two different subtypes of chronic myelomonocytic leukemia (CMML)? Analysis of a series of 119 patients", Leukemia Research , 21(Suppl 1), P27.
10. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R., et al. (1994) "The chronic myeloid leukemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia group", British Journal of Haematology, 87, 746-754.
11. Harris, N.L., Jaffe, E.S., Diebold, J., Flandrin, G., Muller-Hermelink, H.K., et al. (1999) "WHO classification of neoplastic diseases of the hematopoietic and lymphoid tissues", Journal of Clinical Oncology, 17, 3835-3849.
12. Bennett, J.M. (2000) "WHO-Classification of the acute leukemias and myelodysplastic syndromes", International Journal of Hematology, 72, 131-133.
13. Padua, R.A., Guinn, B.A., Al-Sabah, A.I., Smith, M., Taylor, C., Pettersson, T., et al. (1998) "RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias", Leukemia, 12, 878-892.
14. Pitini, V., Arrigo, C., Teti, D., Barresi, G., Righi, M. and Alo, G. (2003) "Response to STI571 in chronic myelomonocytic leukemia with platelet derived growth factor beta receptor involvement", Haematologica, 88, 5.
15. Fenaux, P., Beuscart, R., Lai, J.L., Jouet, J.P. and Bauters, F. (1988) "Prognostic factors in adult chronic myelomonocytic leukemia: an analysis of 107 cases", Journal of Clinical Oncology, 6, 1417-1424.
16. Tefferi, A., Hoagland, H.C., Therneau, T.M. and Pierre, R.V. (1989) "Chronic myelomonocytic leukemia: Natural history and prognostic determinance", Mayo Clinic Procedures, 64, 1246-1254.
17. Onida, F., Kantarijan, H.M., Smith, T.L., Ball, G., Keating, M.J., Estey, E.H., et al. (2002) "Prognostic factors in scoring system in chronic myelomonocytic leukemia", Blood, 99, 840-849.
18. Goasguen, J.E., Garand, R., Bizet, M., et al. (1990) "Prognostic factors of myelodysplastic syndromes. A simplified 3-D scoring system", Leukemia Research, 14, 255-262.
19. Solal-Celigny, P., Desaint, B., Herrera, A., Chastang, C., Amar, M., Vroclans, M., et al. (1984) "Chronic myelomoncytic leukemia according to FAB classification: analysis of 35 cases", Blood, 63, 634-638.
20. Germing, U., Strupp, C., Aivado, M. and Gattermann, N. (2000) "New prognostic parameters for chronic myelomonocytic leukemia?" Blood, 100, 731-733.
21. Ribera, J.M., Cervantes, F. and Rozman, C. (1987) "A multivariate analysis of prognostic factors in chronic myelomonocytic leukaemia according to the FAB criteria", British Journal of Haematology, 65, 307-311.
22. Groupe Français de Cytogenetique Hematologique (1991) "Chronic myelomonocytic leukaemia: Single entity or heterogeneous disorder A prospective multicenter study of 100 patients", Cancer Genetics Cytogenetics, 55, 57-65.
23. Catalano, L., Improta, S., de Laurentiis, M., Molica, S., Majolino, I., Musto, P., et al. (1996) "Prognosis of chronic myelomonocytic leukemia", Haematologica, 81, 324-329.
24. Worsley, A., Oscier, D.G., Stevens, J., et al. (1988) "Prognostic features of chronic myelomonocytic leukaemia: a modified Bournemouth score gives the best prediction of survival", British Journal of Haematology, 68, 17-21.
25. Stark, A.N., Thorogod, J., Head, C., Roberts, B.E. and Scott, C.S. (1987) "Prognostic factors and survival in chronic myelomonocytic leukaemia (CMML)", British Journal of Cancer, 56, 59-63.
26. Nösslinger, T., Reisner, R., Grüner, H., Tüchler, H., Nowotny, H., Pittermann, E. and Pfeilstöcker, M. (2001) "Dysplastic versus proliferative CMML", Leukemia Research, 25, 741-747.
27. Gonzales-Medina, I., Bueno, J., Torrequebrada, A., Lopez, A., Vallespi, T. and Massague, I. (2002) "Two groups of chronic myelomonocytic leukaemia: myelodysplastic and myeloproliferative. Prognostic implications in a series of a single center", Leukemia Research, 26, 821-824.
28. Aul, C., Gattermann, N., Germing, U., Winkelmann, M., Heyll, A., Runde, V., et al. (1994) "Serum deoxythymidine kinase in myelodysplastic syndromes", Cancer, 73, 322-327.
29. Germing, U., Gattermann, N., Strupp, C., Aivado, M., Haas, R. and Aul, C. (2000) "Validation of the WHO proposals for the classification of myelodysplastic syndromes. A retrospective analysis of 1600 cases", Leukemia Research, 24, 983-992.
30. Molica, S., Iannaccaro, P. and Albeti, A. (1990) "Chronic myelomonocytic leukemia: A test of a proposed staging system", American Journal of Haematology, 35, 129-130.
31. Aul, C., Gattermann, N., Heyll, A., Germing, U., Derigs, G. and Schneider, W. (1992) "Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system", Leukemia, 6, 52-59.
32. Greenberg, P., Cox, C., LeBeau, M.M., Fenaux, P., Morel, P., Sanz, G., et al. (1997) "International scoring system for evaluating prognosis in myelodysplastic syndromes", Blood, 89, 2079-2088.
33. del Canizo, M.C., Sanz, G., San Miguel, J.F., et al. (1989) "Chronic myelomonocytic leukemia - clinicobiological characteristics: a multivariate analysis in a series of 70 cases", European Journal of Haematology, 42, 466-473.
34. Aul, C., Gattermann, N., Germing, U., Runde, V., Heyll, A. and Schneider, W. (1994) "Risk assessment in primary myelodysplastic syndromes: validation of the Düsseldorf Score", Leukemia, 8, 1906-1913.
35. Kerkhofs, H., Hermanns, J., Haak, H.L. and Leeksma, H.W. (1987) "Utility of the FAB classification for myelodysplastic syndromes: Investigation of prognostic factors in 237 cases", British Journal Haematology, 65, 73-81.
36. Sanz, G.F., Sanz, M.A., Vallespie, T., Canizo, M.C., Torrabadella, M., Garcia, S., et al. (1989) "Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients", Blood, 74, 395-408.
37. Storniolo, A.M., Moloney, W.C., Rosenthal, D.S., Cox, C., Bennett, J.M. (1990) "Chronic myelomonocytic leukemia", Leukemia, 4, 766-770.